Search research articles
Contact Us
Filters
Showing results (301-310 of 317) with videos related to
Page
of 32
Sort By:
Blood
|
November 26, 1999
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure
R Hehlmann, A Hochhaus, H J Kolb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations
K Heidrich, C Thiede, K Schäfer-Eckart, et al.
Bone Marrow Transplantation
|
January 14, 2009
Allogeneic hematopoietic SCT for patients with autoimmune diseases
T Daikeler, T Hügle, D Farge, et al.
British Journal of Haematology
|
June 8, 2004
Haematopoetic stem cell transplantation for refractory autoimmune cytopenia
J R Passweg, M Rabusin, M Musso, et al.
Leukemia
|
August 19, 2015
Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial
J M Middeke, R Herbst, S Parmentier, et al.
Leukemia
|
December 2, 2014
Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial
J Schetelig, M Schaich, K Schäfer-Eckart, et al.
Blood Cancer Journal
|
January 16, 2016
Karyotype complexity and prognosis in acute myeloid leukemia
F Stölzel, B Mohr, M Kramer, et al.
Bone Marrow Transplantation
|
July 1, 1997
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells
H D Ottinger, E Albert, R Arnold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2018
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
C Röllig, M Kramer, M Gabrecht, et al.
British Journal of Cancer
|
October 24, 2013
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment
U Thiel, E Koscielniak, F Blaeschke, et al.
Page
of 32
Search research articles
Search
Showing results (301-310 of 317) with videos related to
Sort By:
Page
of 32
Blood
|
November 26, 1999
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure
R Hehlmann, A Hochhaus, H J Kolb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations
K Heidrich, C Thiede, K Schäfer-Eckart, et al.
Bone Marrow Transplantation
|
January 14, 2009
Allogeneic hematopoietic SCT for patients with autoimmune diseases
T Daikeler, T Hügle, D Farge, et al.
British Journal of Haematology
|
June 8, 2004
Haematopoetic stem cell transplantation for refractory autoimmune cytopenia
J R Passweg, M Rabusin, M Musso, et al.
Leukemia
|
August 19, 2015
Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial
J M Middeke, R Herbst, S Parmentier, et al.
Leukemia
|
December 2, 2014
Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial
J Schetelig, M Schaich, K Schäfer-Eckart, et al.
Blood Cancer Journal
|
January 16, 2016
Karyotype complexity and prognosis in acute myeloid leukemia
F Stölzel, B Mohr, M Kramer, et al.
Bone Marrow Transplantation
|
July 1, 1997
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells
H D Ottinger, E Albert, R Arnold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2018
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
C Röllig, M Kramer, M Gabrecht, et al.
British Journal of Cancer
|
October 24, 2013
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment
U Thiel, E Koscielniak, F Blaeschke, et al.
Page
of 32